Evidence map›Paper›PMID 37440306›Full record

ArticleeLife2023

Inhibitory IL-10-producing CD4

Mathew Clement, Kristin Ladell, Kelly L Miners, Morgan Marsden, Lucy Chapman, Anna Cardus Figueras, Jake Scott, Robert Andrews, Simon Clare, Valeriia V Kriukova and 7 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Influence of polyfunctional TbetFrontiers in immunology · 2025
    Trial
  2. Article
  3. Frontiers in immunology · 2026
    Article
  4. Article
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 6 countries.

Mathew ClementDivision of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, United Kingdom.ORCID 0000-0002-9280-5281
Kristin LadellDivision of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, United Kingdom.
Kelly L MinersDivision of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, United Kingdom.
Morgan MarsdenDivision of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, United Kingdom.
Lucy ChapmanDivision of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, United Kingdom.
Anna Cardus FiguerasDivision of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, United Kingdom.
Jake ScottDivision of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, United Kingdom.
Robert AndrewsDivision of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, United Kingdom.
Simon ClareWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, United Kingdom.
Valeriia V KriukovaCenter of Life Sciences, Skolkovo Institute of Science and Technology, Moscow, Russian Federation.
Ksenia R LupyrCenter of Life Sciences, Skolkovo Institute of Science and Technology, Moscow, Russian Federation.
Olga V BritanovaGenomics of Adaptive Immunity Department, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russian Federation.
David R WithersInstitute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.
Simon A JonesDivision of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, United Kingdom.
Dmitriy M ChudakovCenter of Life Sciences, Skolkovo Institute of Science and Technology, Moscow, Russian Federation.
David A PriceDivision of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, United Kingdom.ORCID 0000-0001-9416-2737
Ian R HumphreysDivision of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, United Kingdom.ORCID 0000-0002-9512-5337
Institute of Infection and Immunity · CASkolkovo Institute of Science and Technology · RUInstitute of Immunology · HRRussian Academy of Sciences · RUWellcome Sanger Institute · GB

Funding

Medical Research Council MR/X00077X/1Medical Research Council MR/X00922X/1Wellcome TrustWellcome Trust 100326/Z/12/ZWellcome Trust 110199/Z/15/ZWellcome Trust 207503/Z/17/ZWellcome Trust 209213/Z/17/Z
6 · The paper itself

Abstract

Inhibitory CD4

Indexed as

CytomegalovirusMuromegalovirusAnimalsArginaseCD4-Positive T-LymphocytesInterleukin-10MiceArginaseInterleukin-10arginase-1CD4+ T cellscytomegalovirusIL-10immunologyinfectious diseaseinflammationmicemicrobiologyT-betviruses

Identifiers

PMID37440306
PMCPMC10344424
OpenAlexW4384120415

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.